Health Economics/ Outcomes Research

(148) Health Care Utilization and Medical Costs in New Users of Once-weekly GLP-1 RAs Compared with New Users of DPP-4is Among Individuals with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

(149) Effect of Dipeptidyl Peptidase-4 Inhibitors on Fracture Risk in Patients with Type 2 Diabetes Mellitus: A Network Meta-Analysis of Randomized Controlled Trials

(150) Comparative Effectiveness of Pegcetacoplan (PEG) Versus Ravulizumab (RAV) and Eculizumab (ECU) in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): A Matching-Adjusted Indirect Comparison

(151) PRO Reporting and Methodological Rigor in NSCLC RCTs, a Cause for Concern

(152) Budget impact of risperidone for adults with Autistic Spectrum Disorder in Brazil: a comparative analysis study between epidemiological demand and real-world data

(153) The Bendroflumethiazide versus Indapamide Study for hypertensiON (BISON) cohort study

(154) Outpatient Cost of Care among Patients with Colorectal Cancer (CRC) Treated in the Real-World US Community Oncology Setting

(155) Cost-Effectiveness of Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma in Canada

(156) Anatomical Characterization of Long Bone Femur and Tibial Fractures and Associated Two-Year Risks of Non-Union – A US Database Analysis

(157) Unveiling the impact of Digital Health Interventions in Coronary Heart Disease: A Systematic review and Meta-analysis

(158) Real-world Outpatient Cost of Care among Patients with Ovarian Cancer (OC) Treated in the US Community Oncology Setting

(159) The Effect of Allopurinol and Febuxostat on Blood Pressure in Adults with Chronic Hyperuricemia

(160) Trends of Myocarditis/Pericarditis following SARS-CoV-2 Infection: A Real-World Analysis of a Large US Commercial Claims Database Enriched with Ambulatory EMR Data

(161) Real-world Outpatient Cost of Care among Patients with Breast Cancer Treated in the US Community Oncology Setting

(162) Economic Burden of Gallbladder Cancer in Northeast India: A Hospital-based Prospective Observational Cost-analysis Study

(163) Quality of Life of Patients with Mild Cognitive Impairment or Alzheimer's Disease and Their Caregivers in the United States

(164) Real-world studies evaluating patients with HER2-low breast cancer: A systematic review and meta-analysis

(165) Comparative Efficacy of Pharmacological Interventions for Heart Failure with Reduced Ejection Fraction between Asian and White Patients: A Meta-Analysis of Randomized Outcomes Trials

(166) Clinical Outcomes and Treatment Pattern of Older Patients with Heart Failure Across Different Frailty Severity Status: a Nationwide Cohort Study of 38,843 Newly Hospitalized Heart Failure Patients

(167) Lorlatinib in the first-line treatment of ALK-positive metastatic/advanced non-small-cell lung cancer: a budget impact analysis

(168) Analgesia Versus No-Analgesia in the Management of Neonates Undergoing Mechanical Ventilation in the Intensive Care Setting in Qatar. A Cost-Effectiveness Analysis

(169) Association Between Trajectory of Metabolic Syndrome and Knee Pain over 11 Years in Middle-aged Adults: Evidence from Childhood Determinants of Adult Health (CDAH) Study

(170) Comparative Efficacy of Pharmacological Therapies for Heart Failure with Reduced Ejection Fraction: A Network Meta-Analysis of Randomized Controlled Trials

(171) Treatments and Healthcare Costs Associated with Long Bone Fracture Non-Union - A US Claims Database Analysis

(172) Impact of Early palliative care on humanistic outcomes in patients with advanced cancer

(173) Risk Factors Associated with Long bone Fracture Non-Union – A US Claims Database Analysis

(174) Prevalence of syphilis risk factors in Colorado from 2010-2020

(175) Burden of Narcolepsy from the Perspectives of Direct Medical Cost and Comorbidity in Japan

(176) Compare the generalizability of dapagliflozin and empagliflozin heart failure phase 3 trials to real-world patients in Taiwan

(177) Utilisation and Safety of IV Bolus Formulation of Akis® for use in the Prevention and Treatment of Post-operative Pain in the UK Secondary Setting

(178) Evaluation of Years of Potential Productive Life Lost (YPPLL) due to Premature Mortality from Head and Neck Cancer in Northeast India

(179) Utilization and evaluation of Drug therapy usage among neonates admitted to Neonatal Intensive Care Unit (NICU)

(180) Determination of patients’ quality of life (QOL) and its influencing risk factors associated with QOL in patients with autoimmune systemic vasculitis: a cross-sectional study

(181) Utilization of Comprehensive Metabolic Panels in Regular Patient Management: Investigation of Patient Follow-up Based on Abnormal Test results in a Claims Laboratory Test Result Database

(182) Characterizing Real-World Data Usage for Public Health Research

(183) Cost-effectiveness analysis of ibuprofen versus indomethacin or paracetamol for the treatment of patent ductus arteriosus in preterm neonates

(184) Management of cardiovascular risk in women with and without menopausal symptoms: a real-world depiction of clinical practice in the UK and France

(185) Personalize My Treatment (PMT): The First Pan-Canadian Cancer Patient Databank Suitable for Generation of Oncology Real-World Insights

(186) Cost‑effectiveness evaluation of add‑on dapagliflozin for heart failure with reduced ejection fraction among patients without type 2 diabetes

(187) Comparing immunocompromised status algorithms: Implications for outcomes and clinical trial enrollment

(188) Identifying Cytokine Release Syndrome in Retrospective Databases: A Performance Assessment of a Claims-Based Algorithm

(189) Assessment of medication adherence and the impact of clinical pharmacist interventions on medication adherence among systemic lupus erythematosus patients: a prospective cohort study